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Abstract
Genetic background exerts a strong modulatory effect on the toxicity of aggregation-prone proteins in conformational
diseases. In addition to influencing the misfolding and aggregation behavior of the mutant proteins, polymorphisms in
putative modifier genes may affect the molecular processes leading to the disease phenotype. Mutations in SOD1 in a
subset of familial amyotrophic lateral sclerosis (ALS) cases confer dominant but clinically variable toxicity, thought to be
mediated by misfolding and aggregation of mutant SOD1 protein. While the mechanism of toxicity remains unknown, both
the nature of the SOD1 mutation and the genetic background in which it is expressed appear important. To address this, we
established a Caenorhabditis elegans model to systematically examine the aggregation behavior and genetic interactions of
mutant forms of SOD1. Expression of three structurally distinct SOD1 mutants in C. elegans muscle cells resulted in the
appearance of heterogeneous populations of aggregates and was associated with only mild cellular dysfunction. However,
introduction of destabilizing temperature-sensitive mutations into the genetic background strongly enhanced the toxicity
of SOD1 mutants, resulting in exposure of several deleterious phenotypes at permissive conditions in a manner dependent
on the specific SOD1 mutation. The nature of the observed phenotype was dependent on the temperature-sensitive
mutation present, while its penetrance reflected the specific combination of temperature-sensitive and SOD1 mutations.
Thus, the specific toxic phenotypes of conformational disease may not be simply due to misfolding/aggregation toxicity of
the causative mutant proteins, but may be defined by their genetic interactions with cellular pathways harboring mildly
destabilizing missense alleles.
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Introduction
ALS (OMIM #105400 http://www.ncbi.nlm.nih.gov/entrez/
dispomim.cgi?cmd=entry&id=105400) is a progressive degenera-
tive disorder affecting motor neurons in the brain stem and spinal
cord. Up to 10% of cases have a dominant familial inheritance
pattern with mutations in SOD1 (OMIM *14750 http://www.
ncbi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=147450)
contributing about 20% of those [1,2]. While it is accepted that
disease results from toxic gain of function by the mutant protein
[3–5], the mechanisms contributing to toxicity remain unknown.
Two main hypotheses have been proposed; the first invokes
abnormal chemistry of mutant SOD1 proteins, resulting in
nitration of tyrosine residues on cellular proteins [6] and increased
production of hydroxyl radicals [7,8]. However, mutant SOD1
retains its toxic properties even when abnormal chemical reactions
are greatly reduced [9] suggesting that abnormal chemistry alone
may not be the basis of toxicity. Furthermore, the role of the
dismutase genes in preventing the long-term protein damage have
recently being questioned [10]. The second hypothesis suggests
that, as for many other neurodegenerative diseases, the toxicity is
mediated by misfolding and aggregation of mutant proteins [9,11–
13]. Accumulation of proteinaceous inclusions in conformational
disease indicates an inability of the protein folding quality control
machinery to efficiently recognize, fold, and degrade abnormal
proteins [14], including the mutant forms of SOD1. The role of
damaged proteins is further supported by observations that
elevated levels of molecular chaperones decrease mutant SOD1
toxicity [15,16]. However, it is still unclear how misfolding or
aggregation of SOD1 mutant protein leads to cellular toxicity.
ALS patients harboring different or even the same SOD1
mutations exhibit a high degree of clinicopathologic variation,
including clinical severity, age at onset, and the types of motor
neurons involved [17–20]. Both different biophysical properties of
mutant proteins and variation in the genetic background may
independently modulate the toxicity, providing a range of
phenotypes [21,22]. The importance of genetic interactions in
modulating disease is further underscored by findings that ALS
phenotypes in transgenic mice vary greatly depending on the
strain in which the mutant protein is expressed [23,24].
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misfolding/aggregation behavior and in their interactions with
cellular proteins and pathways may thus provide insights into the
toxic mechanisms and the nature of modifier genes.
To systematically examine the aggregation behavior and genetic
interactions of mutant forms of SOD1, we established a C. elegans
model expressing human SOD1-YFP fusion proteins in the body-
wall muscle cells. The ability to employ dynamic imaging in live
animals throughout their lifespan and availability of both forward
and reverse genetic approaches makes C. elegans an attractive
model to study aggregation toxicity. Similar models in C. elegans
have been used to investigate the aggregation toxicity and genetic
modifiers of polyglutamine expansions and a-synuclein [25–27].
Here, we show that three biophysically distinct [28] mutants of
SOD1 form strikingly polymorphic aggregates in C. elegans.
Expression of mutant SOD1 alone was associated with mild
toxicity. However, when mutant SOD1 was introduced into
genetic backgrounds harboring destabilizing temperature-sensitive
mutations, the toxicity was enhanced significantly and a variety of
toxic phenotypes was observed. These phenotypes reflected both
the specific SOD1 mutant and the loss-of-function of each of the
destabilized temperature-sensitive proteins. Thus, we propose that
specific phenotypes in conformational disease may be influenced
by the mildly destabilizing missense mutations present in the
genetic background.
Results
C. elegans Model for Expression of Wild Type and Mutant
Human SOD1-YFP Fusions
We established a C. elegans model to study SOD1 aggregation
toxicity by expressing wild type and mutant SOD1 in body wall
muscle cells, employing a tissue-specific promoter (pUnc-54) and
C-terminal YFP-tagging scheme (Figure S1A) [25]. The YFP-
tagged wild type SOD1 retained its enzymatic activity (Figure S2,
lane 1), indicating that the tag does not interfere with SOD1
folding. Because various mutations in the SOD1 protein exhibit
different biophysical and biochemical properties [28], we chose
three distinct mutant SOD1 proteins associated with ALS. G85R
is representative of inactive ‘‘metal-binding’’ mutants [29],
deficient in copper and zinc binding and significantly destabilized
[30]. G93A represents ‘‘wild type-like’’ mutants that bind copper
and zinc, exhibit mild loss of thermal stability when fully
metallated, and retain enzymatic activity [31]. 127X (G127in-
sTGGGstop) is a frameshift mutation resulting in a C-terminal
truncation of the last 21 amino acids and a highly unstable protein
[32]. These mutants form protein aggregates with toxic pheno-
types when expressed in mammalian cultured cells and transgenic
mice [3,5,32,33].
Transgenic lines expressing pUnc-54::WT SOD1::YFP ( WT
SOD1), pUnc-54::SOD1-G85R::YFP (G85R), pUnc-54::SOD1-
G93A::YFP (G93A) and pUnc-54::SOD1- G127insTGGGsto-
p::YFP (127X) were established. We verified that SOD1 proteins
expressed in the muscle cells were of the expected molecular sizes
(Figure S1B). Only transgenic lines expressing steady-state levels of
mutant proteins similar to or lower than WT SOD1 were selected
for further study since high expression levels could influence
aggregation and toxicity (Figure S1B).
Wild type SOD1 exhibited diffuse fluorescence in body wall
muscle cells throughout development and during adulthood
(Figure 1A,I) with broad distribution in the muscle belly (the
cytoplasmic space of a muscle cell below the myofilaments) and the
muscle arms (the projections from muscle cells toward the neural
ring). Although WT SOD1 had patchy appearance in some of the
cells, the brighter areas were diffuse upon examination at higher
magnification (insert in Figure 1I), corresponding to soluble
protein (Figure 2A). In contrast, all three mutant SOD1 proteins
presented a punctate fluorescent pattern that appeared in
embryonic stages (Figure 1B–D) and persisted throughout larval
development and adulthood (Figure 1 and Figure S3). In all three
mutant forms of SOD1, we observed both diffuse and punctate
fluorescence corresponding to two populations of protein. Thus,
SOD1 proteins in C. elegans exhibit properties similar to those
observed in other model systems, where only the mutant SOD1
protein forms inclusions when expressed ectopically [3,5,32,33].
Mutant SOD1 Forms Biophysically Distinct Classes of
Protein Aggregates
Accumulation of mutant SOD1 proteins into visible foci,
although consistent with their in vitro aggregation propensity, does
not necessarily indicate the formation of aggregates. We used
dynamic imaging and FRAP analysis to establish the aggregation
state of SOD1 proteins in live animals. As shown in Figure 2A, the
diffusion of WT SOD1-YFP fusion protein in body wall muscle
cells (light blue) was indistinguishable from that of YFP alone
(purple), with nearly complete recovery within the dead-time of
measurement post bleaching. In contrast, the fluorescent foci of all
three mutant proteins exhibited reduced recovery indicative of
immobile aggregate species (Figure 2A,B). G85R and G93A
proteins had 35 and 50% recovery over 275 seconds, respectively,
higher than that observed for foci of well-characterized aggrega-
tion-prone polyQ40 (30%), which contain only an immobile
protein [34]. The recovery of fluorescence in 127X foci continued
beyond 100 sec and reached nearly 60% over the course of the
experiment, which suggests either partially mobile species, or the
presence of multiple populations of protein.
Since these SOD1 mutants have different structural and
biophysical properties in vitro [28], the observed differences in
the fluorescence recovery of aggregates could reflect the presence
of different molecular species or interactions in vivo. We analyzed
Author Summary
Correct folding and stability are essential for protein
function. In cells, a network of molecular chaperones and
degradative enzymes facilitate folding, prevent aggrega-
tion and ensure degradation of the misfolded proteins,
thus maintaining protein homeostasis. In many diseases,
including Amyotrophic Lateral Sclerosis (ALS), expression
of a single mutant protein that misfolds and aggregates
causes cellular toxicity that is strongly dependent on the
genetic background. To address the influence of genetic
background on the toxicity of aggregation-prone proteins,
we established a C. elegans model of misfolding and
aggregation of several distinct ALS-related mutants of
superoxide dismutase 1 (SOD1). In one wild type genetic
background (N2), these proteins exhibited only mild
cellular toxicity despite strong, mutant-specific aggrega-
tion phenotypes. However, when SOD1 mutants were
expressed in the background of mildly destabilized protein
polymorphisms, their toxicity was enhanced and a number
of distinct phenotypes were exposed. These synthetic
phenotypes reflected the loss-of-function of the destabi-
lized polymorphic proteins. Furthermore, the degree to
which each of these phenotypes was exposed depended
on the nature of the SOD1 mutation. These data suggest
that the presence of mildly destabilizing polymorphisms in
the genetic background may modulate and direct the
specific toxic phenotypes in protein aggregation diseases.
Protein Polymorphisms Direct SOD1 Toxicity
PLoS Genetics | www.plosgenetics.org 2 March 2009 | Volume 5 | Issue 3 | e1000399Figure 1. SOD1 mutant proteins aggregate in the body wall muscle cells of C. elegans. (A–D) Fluorescent micrographs of three-fold
embryos showing the diffuse pattern of WT SOD1-YFP fusion (A) and punctate fluorescence of YFP fusions of G93A (B), G85R (C) and 127X (D). (E–H)
G85R animals in all larval stages – L1 (E), L2 (F), L3 (G), L4 (H) – display punctate fluorescent pattern. Inserts are close-ups of the head area. (I–L)
Confocal projections of transgenic adult animals showing the distribution of the SOD-YFP fluorescence (green) and Rhodamine-phalloidin stained
myofilaments (red). WT SOD1 protein exhibits diffuse, if patchy, fluorescence (I), while all mutant strains contain discrete fluorescent foci as well as
some diffuse fluorescence (J through L). Inserts are close-ups of the boxed areas. Scale bars in A and L are 50 and 20 micrometers, respectively. All
images are of representative animals with typical fluorescent patterns.
doi:10.1371/journal.pgen.1000399.g001
Figure 2. Mutant SOD1 proteins form biophysically variable aggregates. (A) FRAP analysis of fluorescent foci of SOD1. WT SOD1 protein
(light blue) is indistinguishable from soluble YFP protein (purple). The fluorescence recovery of G85R and G93A (pink and yellow) is consistent with
stable aggregates, but shows higher initial recovery than polyQ40 species (red). 127X protein demonstrates continued slow recovery consistent with
less stable aggregates (blue). The traces are averages of 7 replicates. (B) Fluorescent micrographs of representative FRAP experiments. Panels I
through III show a concentrated area of fluorescence in WT SOD1 muscle cell before bleaching (pre), immediately post bleaching (6 seconds) and at
the end of the experiment (275 seconds). The bleached area is denoted by a white square. Panels IV through XII show FRAP experiments on G85R (IV
to VI), G93A (VII to IX) and 127X (X to XII) foci, note presence of bleached area even at 275 seconds post bleach. (C). 7.5% native PAGE of extracts from
indicated mutant strains. Mutant proteins contain high molecular weight material that did not enter the gel (lanes 2 to 4). WT SOD1 (lane 1) and G93A
(lane 3) contain a major soluble band (star), which corresponds to enzymatically active SOD1 protein (Figure S2, arrows). G85R (lane 2) and 127X (lane
4) exhibit presence of multiple soluble species, none of which contain enzymatic activity (Figure 2S); 127X also presents unresolved smear below the
aggregated material (bracket), suggesting a continual dissociation of aggregates during electrophoresis. (D) Native extracts were treated with 0.5%
Triton X-100 or 5% SDS for 15 minutes at room temperature and resolved by 5% native PAGE. SOD1 mutants contained aggregates that dissociated
upon SDS treatment (lower panel, lines 4 to 6). Polyglutamine aggregates were used for comparison (line 2). Gels in panels (C) and (D) are
representative of at least three experiments.
doi:10.1371/journal.pgen.1000399.g002
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resis. Extracts from G85R, G93A and 127X lines contained
soluble SOD1 protein in addition to large aggregate species that
did not enter the gel, while extracts of WT SOD1 lines contained
mainly soluble protein (Figure 2C). The distribution of the soluble
G93A protein appeared similar to the WT SOD1, with one major
band containing enzymatically active protein (Figures 2C, star and
S2, arrow). In contrast, G85R and 127X were resolved as multiple
species of different intensities lacking enzymatic activity (Figures 2C
and S2B). This is in agreement with the known native-like
properties of G93A [31] and suggests that human SOD1 proteins
can preserve their characteristics when expressed in C. elegans.
127X extracts also contained a heterogeneous population of
electrophoretic states (Figure 2C, bracket), which could indicate
conformational instability and continual dissociation of larger
molecular species, in agreement with the continual recovery of
fluorescence by FRAP assay (Figure 2A, dark blue).
We further characterized the SOD1 aggregates using detergent
solubility. The large molecular weight material was resistant to
non-ionic detergent (0.5% Triton X-100), but was readily
dissociated by 5% SDS at room temperature (Figure 2D).
Thus, mutant SOD1 in C. elegans appears to form a molecularly
heterogeneous mixture of SDS-labile aggregates and soluble
protein, which for G85R and 127X does not attain a stably
folded, native conformation.
Mutant SOD1 Aggregates Display Morphological
Heterogeneity
The observed biochemical heterogeneity paralleled a striking
heterogeneity in aggregate morphology and distribution in SOD1-
transgenic strains. While all three mutant SOD1 strains had some
cells devoid of visible aggregates, most contained aggregates that
exhibited a wide range of shapes, sizes, and cellular distribution
(Figure 3). The majority of cells (up to 75%) in G85R animals
contained 1–5 aggregates with the apparent size of the fluorescent
foci of 5–7 mm, while some cells contained more than 20 smaller
(less than 1 mm) dispersed aggregates (Figure 3B). Both types of
aggregates exhibited similar biophysical properties by FRAP
analysis (not shown). The G93A strain had a more uniform
distribution of morphological types (Figure 3C), with aggregates
often seen in close apposition to each other (Figure S4A,B). 127X
animals differed from both G85R and G93A strains in that they
contained up to 40% of cells with irregular, non-spherical
aggregates (Figure 3D). The presence of distinct morphological
classes did not depend on the expression level, as we observed a
similar distribution in heterozygous SOD1 animals, despite lower
extent of aggregation (not shown). These data show that the wild
type and three different mutants of SOD1 form morphologically,
structurally and enzymatically different molecular species in vivo,
supporting the possibility of distinct interactions with cellular
components.
Expression of Mutant SOD1 Causes Limited Toxicity
We next asked whether expression of these aggregation-prone
proteins caused toxicity. We assessed several phenotypes as
indicators of dysfunction of muscle cells expressing the transgenes,
such as decrease in motility of animals, disturbance of ultrastruc-
tural organization of myofilaments, developmental defects, and
egg-laying defects. The motility of WT SOD1 animals grown at
15uC was similar to that of wild type (N2) strain on the second day
of adulthood, as measured by number of body bends per minute
(Figure 4A). In contrast, animals expressing G85R, G93A or 127X
SOD1 mutant proteins had 25–30% reduction in motility relative
to that of N2 animals. This decrease in motility was only minimally
enhanced by the sixth day of adulthood (Figure 4A, light grey
bars).
To assess the ultrastructural organization of myofilaments, we
visualized actin filaments with Rhodamine-labeled phalloidin. We
found no major disruptions of the organization of actin filaments
in cells containing aggregates in either of three mutant strains
(Figures 4B,S 4 A). In fact, SOD1 aggregates were localized to a
different focal plane than the myofilaments (Figure S4B), unlike
polyQ aggregates, which were found intercalating into filaments
and disrupting their structure (Figure S4AVII and AVIII).
Dysfunction of muscle cells during embryonic development
leads to defective elongation of the body shape of C. elegans and to
embryonic lethality (emb) or hatching of deformed, growth arrested
larvae (lva). Although SOD1 mutant proteins aggregate already in
embryos, neither of the mutant SOD1 strains exhibited substan-
tially elevated emb+lva phenotype relative to the WT SOD1 strain
(Table 1). The highest toxicity was in G85R strain (8.2%
phenotype, compared to 1.8% in WT SOD1). Likewise, despite
the presence of aggregates in vulva muscle cells, no increase in egg
laying defect was found in mutant SOD1 strains (Table 1)
compared with WT SOD1 strain. Thus, under given experimental
conditions, expression of mutant SOD1 proteins seems to exert
limited toxicity in the muscle cells of C. elegans.
The Toxicity of Mutant SOD1 in Muscle Cells Is
Modulated and Directed by Destabilizing Protein
Polymorphisms
The relatively mild toxicity, despite misfolding and aggregation
of mutant SOD1, indicates that the putative toxic species are
Figure 3. Mutant SOD1 forms morphologically distinct aggre-
gates. Projections of confocal Z-stacks with several adjacent muscle
cells; punctate lines delineate individual cells, red staining shows
myofilaments stained with Rhodamine-phalloidin. G85R protein (B)
forms morphologically diverse aggregates, including large foci indicat-
ed by arrowheads and small dispersed foci, indicated by arrow.
Aggregates in about 40% of cells of 127X animals appear as irregular,
elongated foci (D, arrows and inserts in Figure 1 J–L). Scale bar in A is 10
micrometers. Images are selected as representative of typical aggrega-
tion morphology among at least 100 imaged cells per genotype.
doi:10.1371/journal.pgen.1000399.g003
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control machinery. We had previously found that metastable
temperature-sensitive (ts) mutations in various unrelated genes,
such as unc-15, unc-45 and let-60, coding for paramyosin(ts), UNC-
45(ts) and Ras(ts) proteins, respectively, destabilized the cellular
folding environment and modulated the toxicity of polyQ
expansions [35]. To examine whether protein polymorphisms in
genetic background could influence SOD1 toxicity, we introduced
WT and mutant SOD1 proteins into ts mutant strains and assayed
ts phenotypes at the permissive temperature. WT SOD1 showed
no synthetic toxicity with ts mutants. In contrast, G85R, G93A
and 127X mutants of SOD1 caused exposure of each specific ts
phenotypes at permissive temperature (Table 1).
Loss of function of paramyosin during embryonic development
leads to defects in muscle structure and thus to the emb+lva
phenotype [36]. Expression of mutant SOD1 in the paramyosin(ts)
strain caused differential exposure of these phenotypes at the
permissive temperature (Table 1), depending on the identity of the
SOD1 mutant: expression of G85R resulted in 55% of emb+lva at
15uC, 127X had 33% of emb+lva phenotype, and G93A had
intermediate toxicity. The surviving animals had very few
progeny. To ask whether this toxic interaction is specific to
paramyosin, we crossed SOD1 strains to a strain harboring a ts
mutation in unc-45 gene. Expression of SOD1 mutant proteins in
unc-45(ts) genetic background resulted in exposure of egg laying
and reproductive phenotype (egl+rep) at the permissive temperature
(Table 1). This phenotype is characteristic of dysfunction of UNC-
45-expressing embryonic muscle cells, vulva muscle cells and
gonad sheath cells, and is present in a 100% of unc-45(ts) mutant
animals at the restrictive temperature. Here, G93A exhibited over
80% toxicity at 15uC, compared with less than 5% for either
G93A or UNC-45(ts) expressed alone. Furthermore, the surviving
animals expressing both G93A and UNC-45(ts) developed into
severely uncoordinated (Figure S5), sick adults.
Paramyosin and UNC-45 both affect the formation of
myofilaments: paramyosin is a structural component and UNC-
45 regulates myosin assembly. To assess whether SOD1 mutants
were toxic towards a metastable mutant in a different cellular
pathway, we crossed SOD1 strains to a strain expressing a
temperature-sensitive Ras variant. Expression of G85R and G93A
in ras(ts) background did not have strong effects on embryonic
lethality (Table 1), while 127X, which was the least toxic with
paramyosin(ts) and UNC-45(ts), caused lethality in 23% of
embryos. SOD1 mutant proteins did cause Ras(ts) animals to
Figure 4. SOD1 mutants exert mild toxicity in the body-wall
muscle cells. (A) Body bends of individual animals per minute were
measured. Expression of mutant SOD1 proteins lead to 25 to 30%
decrease in motility on day 2 of adulthood (dark grey bars), and further
decrease by approximately 10% on day 6 of adulthood (light grey bars).
Error bars are standard error of the mean, n$15. P,0.001 between N2
and each SOD1 strain, except where indicated (ns). (B)S O D 1
aggregation does not disrupt the myofilaments structure. Panel I
shows distribution of G85R aggregates in several muscle cells, panel II
shows Rhodamine-phalloidin staining of filaments in same cells. Both
panels represent a single confocal plane with aggregates (I) or filaments
(II) in focus.
doi:10.1371/journal.pgen.1000399.g004
Table 1. SOD1 toxicity is modulated by destabilizing protein polymorphisms.
15uC 25uC
phenotype protein expressed SOD1 param(ts) Ras(ts) SOD+param(ts) SOD+Ras(ts) param(ts) Ras(ts)
emb+lva WT SOD 1.8+/21.2 0.9+/21.6 **
G85R 8.2+/22.5 55.1+/212.8 7.1+/28.0
G93A 3.8+/21.6 44.4+/28.8 10.6+/22.8
127X 0.3+/20.4 33.8+/29.5 23.3+/24.0
param(ts) 6.8+/20.1 100+/20.0
Ras(ts) 3.5+/22.7 100+/20.0
phenotype protein expressed SOD1 UNC-45(ts) Ras(ts) SOD+UNC-45(ts) SOD+Ras(ts) param(ts) Ras(ts)
egl+rep WT SOD 6.3+/24.6 9.5+/23.0 **
G85R 7.1+/22.1 64.8+/26.6 14.4+/29.2
G93A 3.4+/21.8 81.0+/28.5 30.9+/28.3
127X 5.5+/23.9 54.6+/217.3 72.3+/212.0
UNC-45(ts) 3.4+/20.1 100+/20.0
Ras(ts) 6.9+/24.0 93.1+/27.0
**- these phenotypes were not measured due to inability to obtain double homozygous animals.
doi:10.1371/journal.pgen.1000399.t001
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exposed in 127X and 14% in G85R animals. The ts strain by
itself, however, did not present the same egg laying defect (egl)a t
25uC. Instead, Ras(ts) animals raised at the restrictive temperature
had a fluid-filled appearance with degenerated gonads, and
produced few embryos (100% reproductive phenotype, rep). Note
that Table 1 shows a combined egl+rep phenotype. Ras is
ubiquitously expressed, and pleiotropic phenotypes that are
exposed at the restrictive temperature reflect its dysfunction in
different cell types. The egl phenotype exposed by SOD1mutants
in ras(ts) background is likely due to the genetic interaction
between the two mutations specifically in the in vulva muscles or
gonad sheath cells, where the Unc-54 promoter driving SOD1
expression is active.
These data show that while expression of the three distinct
SOD1 mutants in the wild-type N2 strain of C. elegans leads to mild
toxicity, their expression in the genetic backgrounds harboring
diverse temperature-sensitive mutations uncovers toxic pheno-
types, with each SOD1 mutant affecting the activity of a given
metastable protein to different extents.
Discussion
We show here that introduction of mildly destabilized protein
polymorphisms into the defined genetic background of C. elegans
modulates the toxicity of three mutant SOD1 proteins, leading to
the development of specific toxic phenotypes. While either SOD1
aggregation or loss-of-function of metastable ts proteins can each
be viewed as a separate consequence of failure of protein folding
homeostasis, the toxic phenotypes observed here resulted from
their genetic interaction and thus were directed by the nature of
the ts mutation present. Similar to ts mutations in C. elegans, the
phenotypic expression of mildly destabilizing protein polymor-
phisms in higher organisms is thought to depend on the robustness
of the protein folding environment [37]. Thus, the demand on the
folding resources as a consequence of aging, proteotoxic
conditions, and genetic background, may alter the threshold for
the toxicity of an aggregation-prone protein, while specific
pathways and protein complexes containing such polymorphisms
may direct cell-type specific phenotypes.
C. elegans Model for SOD1 Aggregation and Toxicity
We established a C. elegans model in which aggregation, toxicity,
and cellular interactions can be directly compared between
different SOD1 mutants. Furthermore, as models of other
aggregation-prone proteins, such as polyglutamine expansions
[25], a-synuclein [27], and Ab [38] use similar expression schemes
in the same N2 genetic background, these C. elegans models could
be instrumental in deciphering both common and protein-specific
regulation of aggregation or toxicity. Expression of three different
ALS-related mutants of SOD1 in body-wall muscle cells of C.
elegans lead to mild cellular disfunction and appearance of protein
aggregates with distinct morphological characteristics. We also
observed an unexpected variability of aggregate morphology in
neighboring cells of the same animal, which could indicate that
factors other than genetically encoded interactions also affect the
fate of SOD1 in the cell. Similar stochastic variability between
muscle cells of the same animal was previously reported with
respect to onset of sarcopenia in wild type C. elegans [39].
We find that ALS-related SOD1 variants exert a potent
destabilizing influence on the functionality of metastable temper-
ature-sensitive proteins at permissive conditions, exposing a range
of phenotypes that are not present in strains expressing SOD1
mutants alone. Moreover, the most toxic of the SOD1 mutants
(127X) in the Ras(ts) background was the least toxic in the
paramyosin(ts) background, whereas the G85R mutation was most
toxic with paramyosin(ts). Strain-dependent differences in SOD1
toxicity were previously observed in a mouse model carrying
G86R mutation in murine SOD1 (corresponding to G85R in
human SOD1), with complete suppression of toxicity up to
2.5 years in one genetic background, but a rapid onset of paralysis
by 90–120 days in a different genetic background [23]. Our data
suggests that mildly destabilizing missense mutations, present in
the genetic background, could effect the exposure of specific
phenotypes.
Disruption of Protein Folding Is a Common Mechanism
of Toxicity of Aggregation-Prone Proteins
The nature of the toxicity of aggregation-prone proteins
remains one of the central questions for diseases of protein
conformation. We have previously showed that unrelated ts
mutations caused premature aggregation of polyQ-expanded
proteins [35]. Furthermore, metastable proteins encoded by these
ts mutations were found to misfold and lose function in polyQ
strains, indicating that protein folding homeostasis was disrupted
by chronic protein misfolding. Unlike polyQ, mutant SOD1
proteins, though highly aggregation-prone, exhibited much lower
toxicity on their own. The demonstration that toxicity of both
mutant SOD1 and polyQ expansions can be modulated by
metastable proteins supports our contention that the proteostasis
network [40] is sensitive to cumulative protein damage, and that
the disruption of protein folding may be a common mechanism
that underlies the toxicity of different aggregation-prone proteins.
Aggregation-Prone Proteins and Mildly Destabilized
Protein Polymorphisms Compete for Folding Resources
Each of the SOD1 mutant proteins used in this study exhibits
distinct biophysical properties in vitro [28], and forms morpholog-
ically, structurally and enzymatically distinct molecular species and
aggregates in C. elegans. It is thus possible that SOD1 mutant
proteins form different intermediate folding states in vivo depending
on the nature of the mutation, and as such may possess different
functional interactions with the folding machinery of the cell.
Indeed, G85R and G93A proteins were recently shown to have
different interactions with HSP70 in cultured cells [41]. On the
other hand, the structure and functions of paramyosin, UNC-45,
and Ras are diverse (a structural coiled-coil protein, a soluble TPR
domain-containing protein and a small GTPase, respectively) and
these proteins are not overexpressed as they are expressed from
their endogenous chromosomal loci. Thus, it is unlikely that the
synergistic effects on toxicity are because of direct and specific
molecular interactions between these protein polymorphisms and
mutant SOD1. This is in agreement with our previous observation
that polyQs cause misfolding of metastable proteins in the absence
of direct molecular interactions [35], and with a recent report that
many of the modifiers of toxicity of polyQ-expanded ataxin-3 in
Drosophila also rescue the generic toxicity of protein misfolding due
to the reduced function of HSP70 [42]. Furthermore, both the
functionality of metastable proteins and polyglutamine aggrega-
tion can be compromised by neuronally-mediated overexcitation
of the muscle cells in C. elegans [43]. These findings parallel recent
computational evidence that the selection against the toxicity of
misfolding due to mistranslation exerts strong evolutionary
pressure specifically on the highly expressed proteins [44],
indicating that the flux of destabilized proteins in a cell bears a
significant fitness cost, and that folding resources are indeed
limiting. In support of this, we show that overexpression of the
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types in a strain co-expressing an SOD1 mutant G93A and a
metastable ts mutant of UNC-45 (Figure S5B). Thus, we propose
that the genetic interactions between disease-causing mutations
and mildly destabilizing protein polymorphisms are mediated at
the cellular level by competition of their respective gene products
for folding resources.
Cell-Type Specific Toxicity of Aggregation-Prone Proteins
This hypothesis could offer an explanation for the apparent
paradox of cell-type-specific toxicity caused by ubiquitously
expressed toxic proteins in conformational diseases. Indeed, in
SOD1-related ALS, Huntington’s disease, and Alzheimer’s
disease, specific neuronal subtypes are affected despite ubiquitous
expression of SOD1, huntingtin and APP, respectively. The
differential modulation of mutant SOD1 toxicity in C. elegans by
specific ts mutations suggest that the presence of mildly
destabilizing protein polymorphisms in the genetically diverse
human population could direct such specific phenotypes: because
each cell type contains characteristic complement of expressed
proteins, the genetic interactions of aggregation-prone proteins
with destabilizing polymorphisms are expected to manifest in a cell
type-specific manner. The disease variability across the population
suggests that such protein polymorphisms may be specific to
individuals or families, and missed in the population-based linkage
analyses. A recent study found that up to 70% of rare missense
alleles are mildly deleterious in humans [45]; some of these
polymorphisms may result in the production of metastable or
folding-deficient proteins [46,47]. Identification of cell-specific
pathways or protein complexes, which may disfunction when
folding or stability of their components is challenged by co-
expression with an aggregation-prone protein, may thus provide
specific toxic mechanisms for conformational diseases and help
focus the search for disease-modifying polymorphisms.
Materials and Methods
Nematode Strains and Growth Conditions
Nematodes were grown on NGM plates seeded with E. coli
OP50 strain. Animals were synchronized by picking L4 larva or
pre-comma stage embryos onto fresh plates. Assays were
performed with young adult animals, at the second day of
reproductive adulthood at either 15uC (3.5 days after L4 stage) or
25uC (2 day after L4 stage). C. elegans strains were obtained from
the Caenorhabditis Genetic Center. Ts mutants were: paramyo-
sin(ts) - CB1402[unc-159(e1402)], UNC-45(ts) - CB286[unc-
45(e286)] and Ras(ts) - SD551[let-60(ga89)].
The SOD1 transgenic strains were created by injection and
integration of complex arrays, allowing for uniform expression of
transgenes. Human SOD1 sequences were obtained by PCR
amplification from plQL01 or plQL03 (gift from Dr. Q. Liu,
Harvard Medical School), and cloned into a Fire Lab pPD30.38
plasmid. DNA mixture for injection contained 1 ng of linearized
plasmid DNA and 100 ng of worm genomic DNA digested with
PvuII (NEB).
Crosses between SOD1 transgenic and ts strains were
performed by first mating N2 males with SOD1 hermaphrodites,
and subsequently mating SOD1 heterozygous fluorescent males
with ts hermaphrodites. 3–5 fluorescent F1 hermaphrodite
progeny from these crosses were allowed to self, and 15–20 F2
fluorescent progeny were singled onto individual plates. Plates
containing 100% temperature-sensitive progeny were used for
generation of double-homozygous strains. To generate a strain
double homozygous for G85R and Ras(ts), a singe fluorescent F2
hermaphrodite exhibiting a strong muv phenotype was picked
directly from a pool of F2 progeny. We could not generate a WT
SOD+Ras(ts) animals, presumably due to close genetic location of
respective loci.
We noted that strains co-expressing SOD1 and ts mutant
proteins tended to accumulate suppressors, similar to what was
observed with polyQ expansions [35]. Strains with low progeny
number were particularly unstable, resulting in segregation of
strains revertant for the toxic phenotype either during selection of
homozygotes or in the first few generations thereafter, or in
gradual improvement of fitness of the entire population (data from
such strains were discarded). All double homozygous lines were
periodically re-built, and assays were performed within two weeks
of obtaining double homozygous animals.
Biophysical Characterization and Enzymatic Assay
Fluorescence recovery after photobleaching (FRAP) analysis was
performed as previously described [48]. Imaging was performed
on a Zeiss LSM 510 Meta confocal microscope. YFP alone
(polyQ0) and polyQ40 strains, used as controls for soluble and
stably aggregated protein species, are described in [34].
For native extracts, nematode pellets were mechanically
disrupted, lysed in native lysis buffer (50 mM Tris pH7.4, 5 mM
MgCl2, 0.5% Triton-X 100, 0.2 mM PMSF, 1 ug/ml Leupeptin,
1 ug/ml Pepstatin A, Complete protease inhibitor (Roche)) and
centrifuged for 1 min at 306g (Eppendorf 5417C centrifuge). All
reagents were from Sigma, unless indicated otherwise. This
protocol is optimized for the removal of debris and large fragments
of cuticle while preserving the majority of aggregates in the
supernatant, verified by examination of supernatant under
fluorescent microscope. For detergent solubility, native extracts
were incubated in the indicated detergent for 15 min at room
temperature prior to resolving by native PAGE. 20 or 30
micrograms total protein was run on a 5% or 7.5% continuous
native gels. Gels were imaged on Storm 860 scanner (Molecular
Dynamics) with ImageQuant software to detect YFP fluorescence,
or processed for the in-gel enzymatic assay.
Immunostaining and Microscopy
For epifluorescence, nematodes were mounted on 1% agarose
pads with 1 mM levamisole and imaged using Zeiss Axiovert 200
microscope. For immunofluorescence and confocal imaging,
synchronized adults were fixed, permeabilized and stained with
Rhodamine-phalloidin (Molecular Probes), as described previously
[35], and imaged with Zeiss LSM 510 Meta confocal microscope
through a 4061.0 numerical aperture objective with either a 514-
nm or 543-nm line for excitation.
Motility Assay
To measure motility, nematodes at indicated age were placed
individually in a drop of M9 buffer and acclimated for 1 min; the
completed body bends were counted for 1 min. At least15 animals
were used per experiment. Similar decrease in motility was found
by this method and by measuring rate of movement of animals
raised at 20uC on a plate seeded with OP50 bacteria (not shown).
Assays for Specific Temperature-Sensitive Phenotypes
For emb+lva at 15uC, freshly laid pre-comma stage embryos were
picked onto new plates. Unhatched embryos and larvae that
hatched but did not crawl or were severely deformed were scored
after 2 days. Alternatively, young adults were acclimated to 25uC
for 1 day prior to egg laying, transferred onto new plates and
allowed to lay embryos. Embryos were picked and scored one day
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experiment and experiments were repeated at least three times.
To score egl+rep and severe uncoordination, 30 L4 larvae grown
at 15uC were picked to a fresh plate and incubated for 3 days at
15uC or 1.5 days at 25uC. Animals retaining eggs or containing
three-fold embryos (detected with Nomarski optics) were scored as
egg laying defective (egl). Animals with degenerated gonads, sterile,
and those accumulating oocytes were scored as having a
reproductive defect (rep). Animals that did not move on their
own or did not exhibit sinusoidal movement pattern after being
prodded were scored as severely uncoordinated. Experiments were
repeated at least three times.
Supporting Information
Figure S1 (A) Schematic representation of the SOD1-YFP
expression constructs. The Unc-54 promoter/enhancer and
39UTR direct expression of the fusion protein in body wall,
intestinal, anal depressor, and sphincter muscles, as well as sex-
specific muscles that develop postembryonically (WormBase). (B)
Steady-state protein levels of SOD1 WT and mutant proteins.
G85R and 127X proteins are expressed at level similar to the WT
SOD1, while G93A is expressed at lower steady-state level. The
level of YFP protein in the control strain is more than 2 fold higher
than in any of the SOD1-YFP strains. The upper panel shows
immunoblot with anti-YFP antibody, the bottom panel - with anti-
tubulin antibody. 10 individual young adult animals were picked
from indicated strains, boiled (15 min) in SDS sample buffer and
resolved on 10% SDS gel. Immunoblots were scanned and
quantified using Odyssey Infrared Imaging System (LI-COR
Biosciences). The numbers below the gel represent quantitation of
YFP signal normalized to tubulin.
Found at: doi:10.1371/journal.pgen.1000399.s001 (0.53 MB TIF)
Figure S2 Only soluble species of WT SOD1 and G93A
proteins possess specific dismutase activity. G93A extract (line 3,
arrow) contains one main population of similar electrophoretic
mobility (A) and enzymatic activity (B) to the WT SOD1 (line 1,
arrow). The aggregated G93A protein is inactive (arrowhead), as is
G85R and 127X protein (lanes 2 and 4, respectively). Native
extracts were resolved by 5% native PAGE (same gel as in
Figure 2D, upper panel), YFP fluorescence was visualized with
Storm 860 scanner, and in-gel enzymatic activity assay was
subsequently performed as previously described [49]. The assay
measures SOD1-mediated inhibition of nitro blue tetrazolium
(NBT) reduction by riboflavin and TEMED. 20 micrograms total
protein was used for this assay.
Found at: doi:10.1371/journal.pgen.1000399.s002 (1.34 MB TIF)
Figure S3 The aggregation pattern and morphological variabil-
ity of aggregates in G85R strain. (A) Aggregation pattern of G85R
mutant protein at 20uC is similar to that observed at 15uC (shown
in Figure 1H). Shown are Nomarski and fluorescent micrographs
of representative L4 WT SOD1 and G85R animals. The scale bar
in panel I is 50 micrometers. (B) Area posterior to the vulva is
shown in four individual young adult G85R animals grown at
15uC. The nematodes were anesthetized, but not fixed, prior to
microscopic examination.
Found at: doi:10.1371/journal.pgen.1000399.s003 (3.56 MB TIF)
Figure S4 SOD1 aggregates do not disrupt myofilaments and
localize to the muscle belly. (A) Phalloidin-stained myofilaments
(red) appear intact in the cells containing SOD1 aggregates (green,
panels I through VI). In contrast, polyQ40 aggregates (panel VII)
intercalate into myofilaments and disrupts their continuity (panel
VIII). Arrows in each panel point to the location of selected
aggregates. Panels I, III and V, showing SOD1 aggregates, and II,
IV and VI, showing myofilaments in corresponding cells, are in
different confocal planes. The scale bar in I is 10 micrometers. (B)
G93A aggregates are localized to the cytoplasmic area beneath the
myofilaments - muscle belly. Confocal image through the middle
plane of individual nematode, the muscle cells on the ventral side
(towards the bottom of the image) are seen edge-on. Short arrows
indicate positions of the muscle quadrants, arrowheads outline an
oocyte. Several G93A aggregates (green) are seen in close
apposition to each other (long arrow), adjacent to myofilaments
(red). The scale bar is 10 micrometers.
Found at: doi:10.1371/journal.pgen.1000399.s004 (3.06 MB TIF)
Figure S5 Expression of SOD1 mutants in unc-45(ts) back-
ground leads to defect in cellular protein folding and exposure of
severe uncoordination phenotype. (A) Double homozygous
animals were scored on day 2 of adulthood. Animals that did
not move on their own or did not exhibit sinusoidal movement
pattern after being prodded were scored as severely uncoordinat-
ed. The hatched bar represents unc-45(ts) animals at 25uC. (B)
Overexpression of heat-shock transcription factor HSF-1 rescues
the synergistic toxicity between G93A and UNC-45(ts) mutant
proteins. HSF-1 is expressed from ubiquitous promoter let-858,a s
described in [50].
Found at: doi:10.1371/journal.pgen.1000399.s005 (0.35 MB TIF)
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